Introduction

Rite Aid acquired 1,854 Brooks and Eckerd stores and six distribution centers from The Jean Coutu Group in June 2007, creating the largest drugstore chain on the East Coast and significantly strengthening its position as the third largest US drugstore chain.

Scope of this research

• Contains corporate strategy, value chain presence and SWOT Analysis
• Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
• Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Research and analysis highlights

Rite Aid is a retail drugstore chain operator engaged in the sale of prescription drugs and other merchandise. It operates drug stores in 27 states across the US and in the District of Columbia. It offers prescription drugs, OTC medications and also offers private brand products such as Rite Aid Ibuprofen, Rite Aid Isopropyl, and Rite Aid Aspirin.

Rite Aid primarily operates through retail drug segment. The segment's operations are classified into pharmacy, front-end merchandise, and others.

Rite Aid introduced a new pharmacy management and dispensing system called 'Nexgen' across its stores. The system equips pharmacists with better tools to meet the customer needs. The company's customers are provided with an easy and convenient way to order refills over the telephone or the internet, using the company's automatic refill program.

Key reasons to purchase this research

• Access all the important information and analysis on the company in a single report
• Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
• Gain access to company's adjusted five year financial data along with key ratios and market capitalization